Clinical
Characteristics of Coronavirus Disease 2019 Open Access
--A Review on Laboratory Tests, Comorbidity, and
Complication
Xiaowei Qiu, Yehong Tian, Xin Jiang, Jingnan Xu, Qiaoli Zhang, Jinchang Huang
September
29, 2020
ABSTRACT
Coronavirus
Disease 2019 (COVID-19), a new respiratory disease caused by severe acute
respiratory syndrome virus 2, has emerged as an ongoing pandemic and global
health emergency. This article primarily aims to
describe laboratory tests, comorbidities, and complications, specifically
comprise 1) the incubation period and basic epidemiological parameters, 2)
clinical manifestations, 3) laboratory tests, including routine blood tests,
inflammatory biomarkers, cardiac biomarkers, liver and renal function, and
blood coagulation function, 4) chest imaging features, 5) significant
comorbidities and complications. This information on the disease conditions
would help dissect the disease heterogeneity for appropriately selecting clinical
treatment strategies and therapeutic development.
KEYWORDS
Clinical
characteristics; COVID-19; SARS-CoV2, complication.
Copyright©2020 by the
author(s).
Licensee Global
Clinical and Translational Research. This is an open-access article distributed
under the terms and conditions of the Creative Commons Attribution License
(CCBY4.0, https://creative-commons.org/licenses/by/4.0/),which permits
unrestricted use, distribution, and reproduction in any medium provided the
original work is properly cited.
How
to cite this paper
Qiu,X, Tian Y, Jiang
X, Xu J, Zhang Q, Huang J. Clinical
Characteristics of Coronavirus Disease 2019: A Review on Lab Tests, Comorbidity, and Complication. Glob Clin Transl Res. 2020; 2(3): 85-99. DOI:10.36316/gcatr.02.0035
REFERENCES
1.
Lessler J, Reich
NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute
respiratory viral infections: a systematic review. Lancet Infect Dis. 2009; 9(5):291-300.
2.
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q,
Meredith HR, et al. The incubation period of coronavirus disease 2019
(COVID-19) from publicly reported confirmed cases: Estimation and application.
Ann Intern Med. 2020;172 (9): 577-82.
3.
Lombardi A, Bozzi G, Mangioni D, Muscatello A,
Peri AM, Taramasso L, et al. Duration of quarantine in hospitalized patients
with severe acute respiratory syndrome corona-virus 2 (SARS-CoV-2) infection: a
question needing an answer. J Hosp Infect. 2020;105(3):404-5.
4.
Zhang YY, Li BR, Ning BT. The Comparative
Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus
Infections. Front Immunol. 2020;11:2033.
5.
Tian HY. [2019-nCoV: new challenges from
coronavirus]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(3):235-8.
6.
Backer JA, Klinkenberg D, Wallinga J. Incubation
period of 2019 novel coronavirus (2019-nCoV) infections among travellers from
Wuhan, China, 20-28 January 2020. Euro Surveill. 2020;25(5).
7.
Linton NM, Kobayashi T, Yang Y, Hayashi K,
Akhmetzhanov AR, Jung SM, et al. Incubation period and other epidemi-ological
characteristics of 2019 novel coronavirus infections with right truncation: A
statistical analysis of publicly available case data. J Clin Med.
2020;9(2):538.
8.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et
al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J
Med. 2020;382(18):1708-20.
9.
Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM,
Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: A national
retrospective study. J Infect Public Health. 2020.
10. Bai Y, Yao L,
Wei T, Tian F, Jin DY, Chen L, et al. Presumed asymptomatic carrier
transmission of COVID-19. JAMA. 2020;323(14):1406-7.
11. Argenziano MG,
Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, et al. Characterization and
clinical course of 1000 patients with coronavirus disease 2019 in New York:
retrospective case series. BMJ. 2020;369:m1996.
12. Goyal P, Choi
JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics
of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372-4.
13. Grasselli G,
Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline
characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted
to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574-81.
14. Huang J, Wang A,
Kang G, Li D, Hu W. Clinical course of patients infected with severe acute
respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery. J
Thoracic and Cardiovasc Surg. 2020;160(2):e91-e3.
15. Killerby ME,
Link-Gelles R, Haight SC, Schrodt CA, England L, Gomes DJ, et al. Characteristics
associated with hospitali-zation among patients with COVID-19 - metropolitan
Atlanta, Georgia, March-April 2020. MMWR Morb Mortal Wkly Rep.
2020;69(25):790-4.
16. Livingston E,
Bucher K, Rekito A. Coronavirus disease 2019 and influenza 2019-2020. JAMA.
2020;323(12):1122.
17. Petrilli CM,
Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, et al. Factors
associated with hospital admission and critical illness among 5279 people with
coronavirus disease 2019 in New York City: prospective cohort study. BMJ.
2020;369:m1966.
18. Wang D, Hu B, Hu
C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized
patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA.
2020;323(11):1061-9.
19. Alsofayan YM,
Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of
COVID-19 in Saudi Arabia: A national retrospective study. J Infect Public
Health. 2020;13(7):920-5.
20. Docherty AB,
Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133
UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characteri-sation
Protocol: prospective observational cohort study. BMJ (Clinical research ed).
2020;369:m1985.
21. Hong KS, Lee KH,
Chung JH, Shin KC, Choi EY, Jin HJ, et al. Clinical features and outcomes of 98
patients hospitalized with SARS-CoV-2 infection in Daegu, South Korea: A brief
descriptive study. Yonsei Med J. 2020;61(5):431-7.
22. Biagi A, Rossi
L, Malagoli A, Zanni A, Sticozzi C, Comastri G, et al. Clinical and epidemiological
characteristics of 320 deceased patients with COVID-19 in an Italian Province:
A retrospective observational study. J Med Virol. 2020.
23. Shi S, Qin M,
Cai Y, Liu T, Shen B, Yang F, et al. Characteristics and clinical significance
of myocardial injury in patients with severe coronavirus disease 2019. Eur
Heart J. 2020;41(22):2070-9.
24. Wang L, Shen Y,
Li M, Chuang H, Ye Y, Zhao H, et al. Clinical manifestations and evidence of
neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic
review and meta-analysis. J Neurol. 2020;267(10):2777-89.
25. Lechien JR,
Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical
and epidemiological chara-cteristics of 1,420 European patients with
mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335-44.
26. Cao Q, Chen YC,
Chen CL, Chiu CH. SARS-CoV-2 infection in children: Transmission dynamics and
clinical characteri-stics. J Formos Med Assoc. 2020;119(3):670-3.
27. Dong Y, Mo X, Hu
Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in
China. Pediatrics. 2020;145(6).
28. Qiu H, Wu J,
Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36
children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an
observa-tional cohort study. Lancet Infect Dis. 2020;20(6):689-96.
29. Shekerdemian LS,
Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics
and outcomes of children with coronavirus disease 2019 (COVID-19) infe-ction
admitted to US and Canadian pediatric intensive care units. JAMA Pediatr.
2020;174(9):1-6.
30. Feng W, Zong W,
Wang F, Ju S. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a
review. Mol Cancer. 2020;19(1):100.
31. Nguyen-Van-Tam
JS, Openshaw PJ, Hashim A, Gadd EM, Lim WS, Semple MG, et al. Risk factors for
hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom
first wave (May-September 2009). Thorax. 2010;65(7):645-51.
32. Knights H, Mayor
N, Millar K, Cox M, Bunova E, Hughes M, et al. Characteristics and outcomes of
patients with COVID-19 at a district general hospital in Surrey, UK. Clin Med
(Lond). 2020;20(5):e148-e53.
33. Yu N, Li W, Kang
Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and neonatal
outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective,
single-centre, descriptive study. Lancet Infect Dis. 2020; 20(5):559-64.
34. Chen H, Guo J,
Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine
vertical transmission pot-ential of COVID-19 infection in nine pregnant women:
a retrospective review of medical records. Lancet. 2020; 395(10226):809-15.
35. Pierce-Williams
RAM, Burd J, Felder L, Khoury R, Bernstein PS, Avila K, et al. Clinical course
of severe and critical corona-virus disease 2019 in hospitalized pregnancies: a
United States cohort study. Am J Obstet Gynecol MFM. 2020; 2(3): 100134.
36. Knight M, Bunch
K, Vousden N, Morris E, Simpson N, Gale C, et al. Characteristics and outcomes
of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in
UK: national population based cohort study. BMJ. 2020;369:m2107.
37. Breslin N,
Baptiste C, Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K, et al.
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant
women: two weeks of confirmed presentations to an affili-ated pair of New York
City hospitals. Am J Obstet Gynecol MFM. 2020;2(2):100118.
38. Zhu H, Wang L,
Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born
to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51-60.
39. Berenguer J,
Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón J, et al.
Characteristics and predictors of death among 4,035 consecutively hospitalized
patients with COVID-19 in Spain. Clin Microbiol Infect. 2020.
40. Richardson S,
Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting
characteristics, comorbidities, and outcomes among 5700 patients hosp-italized
with COVID-19 in the New York City area. Jama. 2020;323(20):2052-9.
41. Liu J, Liu Y,
Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts
critical illness patients with 2019 coronavirus disease in the early stage. J
Transl Med. 2020; 18(1):206.
42. Lee JY, Hong SW,
Hyun M, Park JS, Lee JH, Suh YS, et al. Epidemiological and clinical characteristics
of coronavirus disease 2019 in Daegu, South Korea. Int J Infect Dis. 2020; 98:462-6.
43. Mao L, Jin H,
Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized
patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):
683-90.
44. Zhang JJ, Cao
YY, Tan G, Dong X, Wang BC, Lin J, et al. Clinical, radiological, and
laboratory characteristics and risk factors for severity and mortality of 289
hospitalized COVID-19 patients. Allergy. 2020.
45. Bao J, Li C,
Zhang K, Kang H, Chen W, Gu B. Comparative analysis of laboratory indexes of
severe and non-severe patients infected with COVID-19. Clin Chim Acta. 2020; 509:180-94.
46. Hao SR, Zhang
SY, Lian JS, Jin X, Ye CY, Cai H, et al. Liver enzyme elevation in coronavirus
disease 2019: A multi-center, retrospective, cross-sectional study. Am J Gastro-enterol.
2020;115(7):1075-83.
47. Yip TC, Lui GC,
Wong VW, Chow VC, Ho TH, Li TC, et al. Liver injury is independently associated
with adverse clinical outcomes in patients with COVID-19. Gut. 2020.
48. Kumar MP, Mishra
S, Jha DK, Shukla J, Choudhury A, Mohindra R, et al. Coronavirus disease
(COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
Hepatol Int. 2020.
49. Huang H, Chen S,
Li H, Zhou X, Dai Y, Wu J, et al. The association between markers of liver
injury and clinical outcomes in patients with COVID-19 in Wuhan. Aliment
Pharmacol & Ther. 2020;52(6):1051-9.
50. Kulkarni AV,
Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, et al. Systematic review
with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Phar-macol
Ther. 2020;52(4):584-99.
51. Uribarri A,
Nunez-Gil IJ, Aparisi A, Becerra-Munoz VM, Feltes G, Trabattoni D, et al.
Impact of renal function on admission in COVID-19 patients: an analysis of the
international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19)
Registry. J Nephrol. 2020;33(4):737-45.
52. Han H, Yang L,
Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of
patients with SARS-CoV-2 infection. Clinical chemistry and laboratory medicine.
2020;58(7):1116-20.
53. Zhang Y, He L,
Chen H, Lu S, Xiong Y, Liu J, et al. Manifes-tations of blood coagulation and
its relation to clinical outcomes in severe COVID-19 patients: Retrosp-ective
analysis. Int J Lab Hematol. 2020.
54. Cheng Z, Lu Y,
Cao Q, Qin L, Pan Z, Yan F, et al. Clinical features and chest CT
manifestations of coronavirus disease 2019 (COVID-19) in a single-Ccnter study
in Shanghai, China. Am J Roentgenol. 2020;215(1):121-6.
55. Bernheim A, Mei
X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in coronavirus
disease-19 (COVID-19): relationship to duration of infection. Radiology.
2020;295 (3):200463.
56. Shi H, Han X,
Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients
with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect
Dis. 2020;20(4):425-34.
57. Zhu J, Zhong Z,
Li H, Ji P, Pang J, Li B, et al. CT imaging features of 4121 patients with
COVID-19: A meta-analysis. J Med Virol. 2020;92(7):891-902.
58. Li Y, Xia L.
Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and
management. Am J Roent-genol. 2020;214(6):1280-6.
59. Xiong Y, Sun D,
Liu Y, Fan Y, Zhao L, Li X, et al. Clinical and high-resolution CT features of
the COVID-19 infection: Comparison of the initial and follow-up changes. Invest
Radiol. 2020;55(6):332-9.
60. Al-Tawfiq JA,
Memish ZA. Diagnosis of SARS-CoV-2 infection based on CT scan vs RT-PCR:
reflecting on experience from MERS-CoV. J Hosp Infect. 2020;105(2):154-5.
61. Sun Z, Zhang N,
Li Y, Xu X. A systematic review of chest imaging findings in COVID-19.
Quantitative imaging in medicine and surgery. 2020;10(5):1058-79.
62. Chen N, Zhou M,
Dong X, Qu J, Gong F, Han Y, et al. Epidemi-ological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan,
China: a descriptive study. The Lancet. 2020;395(10223):507-13.
63. Guan WJ, Liang
WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590
patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020; 55(5):2000547.
64. Wang B, Li R, Lu
Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19:
evidence from meta-analysis. Aging (Albany NY). 2020;12(7):6049-57.
65. Tian Y, Qiu X,
Wang C, Zhao J, Jiang X, Niu W, et al. Cancer associates with risk and severe
events of COVID-19: A systematic review and meta-analysis. International
Journal of Cancer.n/a(n/a).
66. Inciardi RM,
Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, et al. Characteristics and
outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern
Italy. European heart journal. 2020;41(19):1821-9.
67. Chen T, Wu D,
Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased
patients with coronavirus disease 2019: retrospective study. BMJ.
2020;368:m1091.
68. Ramirez J,
Aliberti S, Mirsaeidi M, Peyrani P, Filardo G, Amir A, et al. Acute Myocardial
Infarction in Hospitalized Patients with Community-Acquired Pneumonia. Clinical
Infectious Diseases. 2008;47(2):182-7.
69. Corrales-Medina
VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular
system. The Lancet. 2013;381(9865):496-505.
70. Selby NM, Forni
LG, Laing CM, Horne KL, Evans RD, Lucas BJ, et al. Covid-19 and acute kidney
injury in hospital: summary of NICE guidelines. BMJ. 2020;369:m1963.
71. Arentz M, Yim E,
Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes
of 21 critically Ill pati-ents with COVID-19 in Washington State. JAMA. 2020; 323
(16):1612-4.
72. Brienza N,
Puntillo F, Romagnoli S, Tritapepe L. Acute kidney Injury in coronavirus
disease 2019 infected patients: A meta-analytic study. Blood Purif. 2020:1-7.
73. Hansrivijit P,
Qian C, Boonpheng B, Thongprayoon C, Vallabhajosyula S, Cheungpasitporn W, et
al. Incidence of acute kidney injury and its association with mortality in
patients with COVID-19: a meta-analysis. J Investig Med. 2020;68(7):1261-70.
74. Zhou F, Yu T, Du
R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality
of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort
study. Lancet. 2020;395(10229):1054-62.
75. Sharma P, Uppal
NN, Wanchoo R, Shah HH, Yang Y, Parikh R, et al. COVID-19-associated kidney
injury: A case series of kidney biopsy findings. J Am Soc Nephrol.
2020;31(9):1948-58.
76. Farkash EA,
Wilson AM, Jentzen JM. Ultrastructural evidence for direct renal infection with
SARS-CoV-2. J Am Soc Nephrol. 2020;31(8):1683-7.
77. Su H, Yang M,
Wan C, Yi LX, Tang F, Zhu HY, et al. Renal histopathological analysis of 26
postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98 (1):
219-27.
78. Cheng Y, Luo R,
Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with
in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-38.